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medical management with amiodarone, mexiletine, and dofetilide had been attempted but was unsuccessful at relieving the recurring ventricular arrhythmias. On preoperative TTE, marked hypertrophy of the midventricle and a small apical aneurysm were seen.
A transapical ventriculotomy was made to resect the aneurysm and relieve MVO. The apical aneurysm had a large amount of subendocardial scarring, which was excised together with the aneurysm. The anterolateral papillary muscle was markedly hypertrophied and was shaved to reduce risk of midventricular obstruction.
The patient had an uneventful postoperative course. At follow-up 3 years after surgery, he reports no recurrence of the ventricular arrhythmias and had no further ICD shocks.
CASE 3
A 74-year-old woman was referred to our clinic with a history of recurrent VT refractory to medical treatment with amiodarone, mexiletine, and carvedilol. She had a background of HCM with midventricular obstruction. An ICD was placed, but ventricular arrhythmias led to frequent shocks and multiple electrical storms. Her most recent storm resulted in 13 successive ICD discharges. On preoperative TTE, a resting midventricular gradient of 38 mm Hg was noted, and a large apical aneurysm was seen (Figure 1) , which was thought to be responsible for the recurring ventricular arrhythmias.
Through a transapical incision, a midventricular septal myectomy was performed to relieve intracavitary obstruction, and the large apical aneurysm and underlying scar were excised (Figure 2) . Postoperatively, the patient did not experience any ventricular arrhythmias. She has remained asymptomatic and had no further VT or ICD shocks at 2-year follow-up.
DISCUSSION
Apical aneurysms are thought to arise from high midventricular gradients, causing increased wall stress in the left ventricle and subendocardial ischemia and scarring.
2,3 All 3 of our patients had marked obstruction at the midventricle, which we believe was a significant risk factor leading to aneurysm formation. Ventricular arrhythmias commonly are associated with apical aneurysms in patients with HCM and midventricular obstruction. In these patients, VT often is refractory to medical treatment and may result in electrical storms. 1 In a recent clinical study, Rowin and colleagues 4 recommended conservative treatment of patients with apical aneurysms using anticoagulation for prevention of thromboembolism and ICD for patients with malignant ventricular arrhythmias. These authors specifically cautioned against surgical treatment of apical aneurysms, as they rarely cause heart failure and do not rupture. Catheter ablation may be acceptable in patients with small apical aneurysms in whom a localized arrhythmogenic area is suspected. However, midventricular obstruction and the increased risk of thromboembolism are not managed adequately by catheter-based treatment. Surgical resection of apical aneurysms in patients with MVO and/or nonobstructive apical hypertrophic cardiomyopathy may be indicated if there is recurrent VT refractory to medication, and arrhythmia is thought to arise from extensive endocardial scarring, often associated with sizable aneurysms. 1, 5 Electroanatomic map-guided surgical ablation and cryoablation of apical aneurysms have been reported in the literature. 5 However, in our experience, mapping and cryoablation are not necessary, and we prefer linear resection of the aneurysm and wide excision of surrounding scar tissue. 1 
CONCLUSIONS
In patients with apical aneurysm and electrical storm, resection of the aneurysm and endocardial scarring might reduce the risk of further ventricular arrhythmias, especially recurrence of debilitating electrical storms.
